-
Dec 30, 2024 | 
healio.com | Arshad Khanani |Anthony DeFino |Eamon Dreisbach
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. CHICAGO — In this Healio Video Perspective from the AAO meeting, Arshad M.
-
Dec 10, 2024 | 
theophthalmologist.com | Arshad Khanani
Following the launch of The Ophthalmologist's Retina newsletter this year, we present a round-up of Retina editorials by leaders in the fieldArshad M. Khanani | | Opinion It has been a busy year, full of medical meetings with friends and colleagues from around the globe. One thing is for certain, the future has never looked brighter for our field.
-
Dec 4, 2024 | 
healio.com | Arshad Khanani |Anthony DeFino |Christine Klimanskis
Read more You've successfully added Retina/Vitreous in Ophthalmology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Arshad M.
-
Nov 12, 2024 | 
medscape.com | Arshad Khanani
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Arshad M. Khanani, MD, reflects on updates he has integrated into his practice following insights from the AAO 2024 annual meeting's retina subspecialty day.
-
Nov 4, 2024 | 
healio.com | Arshad Khanani |Anthony DeFino |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. CHICAGO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Arshad M.
-
Oct 23, 2024 | 
medscape.com | Arshad Khanani
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Dr Arshad Khanani previews the 2024 American Academy of Ophthalmology Annual Meeting, particularly the retina subspecialty day focusing on wet age-related macular degeneration (AMD), with highlights such as talks by Dr Barbara Blodi on macular atrophy and Dr Usha Chakravarthy on fibrosis biomarkers.
-
Oct 22, 2024 | 
eyetube.net | Arshad Khanani
Fellow-Eye Dosing of ABBV-RGX-314 Gene Therapy Arshad M. Khanani, MD, MA, FASRS Show Description + Dr. Khanani explains the results of a fellow-eye bilateral dosing study of investigational ABBV-RGX-314 (Regenxbio/Abbvie) gene therapy for wet AMD. Subretinal delivery of the drug led to a 97% reduction in anti-VEGF treatment burden at 9 months. Fellow-Eye Dosing of ABBV-RGX-314 Gene Therapy Arshad M.
-
Aug 26, 2024 | 
nature.com | Ashish Sharma |Peter Kaiser |Frank G. Holz |Sobha Sivaprasad |Taku Wakabayashi |Nilesh Kumar | +3 more
The majority (95.2%) of the ophthalmologists were aware of all the ranibizumab biosimilars available in India. Biosimilar ranibizumab was the most common ranibizumab administered with 50–100% usage in 51% respondents whereas the proportion of originator usage was below 25% in the majority of practices (62.8%) (Fig. 1B).
-
Jul 17, 2024 | 
healio.com | Arshad Khanani |Anthony DeFino |Christine Klimanskis
You've successfully added Retina/Vitreous in Ophthalmology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In this Healio Video Perspective from the ASRS meeting, Arshad M.
-
Jul 15, 2024 | 
healio.com | Arshad Khanani |Anthony DeFino |David Mullin |Christine Klimanskis
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS,discusses efficacy and safety data for the port delivery system ahead of its reintroduction.
